High cyclooxygenase-2 expression in cervical adenocarcinomas

Area of Science:

• Oncology
• Pathology
• Molecular Biology

Background:

• Cervical cancer is a significant global health concern.
• Cyclooxygenase-2 (COX-2) is implicated in various cancers.
• Understanding COX-2 expression in cervical cancer is crucial for prognostic assessment.

Purpose of the Study:

• To investigate the relationship between cyclooxygenase-2 (COX-2) expression and prognostic factors in cervical carcinomas.
• To compare COX-2 expression across different histological subtypes of cervical cancer.
• To evaluate the association of COX-2 with tumor differentiation and invasion.

Main Methods:

• Studied COX-2 expression in 53 cervical cancer tissues (squamous cell carcinomas, adenosquamous cell carcinoma, adenocarcinomas) and 16 normal cervical tissues.
• Utilized immunohistochemistry with polyclonal antibodies on Formalin-fixed, paraffin-embedded tissues.
• Quantified immunoreactivity using an established scoring system.

Main Results:

• Moderate to strong COX-2 expression was observed in 41.5% of cervical cancer tissues, significantly higher than in normal tissues (P = 0.001).
• Adenocarcinomas exhibited significantly higher COX-2 expression (70.6%) compared to squamous cell carcinomas (28.6%) (P = 0.004).
• Deep stromal invasion was inversely correlated with COX-2 expression (P = 0.02), while well-differentiated tumors showed increased COX-2 levels (P = 0.018).

Conclusions:

• Overexpression of COX-2 occurs in both squamous cell carcinoma and adenocarcinoma of the cervix.
• Squamous cell carcinomas demonstrate infrequent and low COX-2 expression.
• Elevated COX-2 expression appears to be significant in cervical adenocarcinomas, potentially indicating a role in their pathogenesis.